Last edition
News about "radioligand therapies "
Evergreen Theragnostics Opens Phase II Small Cell Lung Cancer Clinical Trial in EU
The CCK2-VIEW trial uses 68Ga-EVG321, a peptide-based Radioligand imaging agent administered to patients with small cell lung cancer.
Radioligand Therapies | 18/10/2024 | By Aishwarya
Calyx / Invicro Partners with BAMF Health to Boost Clinical Translation of RLT and IO Agents
Calyx / Invicro has announced a strategic partnership with BAMF Health, a world leader in molecular imaging and theranostics.
Radioligand Therapies | 10/06/2024 | By Aishwarya | 116
Navigate BioPharma Services Unveils New Assay for Precise Measurement of Radioligand Therapies
Navigate BioPharma Services, Inc. has introduced a new assay for quantifying pharmacodynamic markers of radioligand therapies in tumors.
Radioligand Therapies | 01/06/2024 | By Aishwarya | 166
Novartis to Acquire Mariana Oncology to Expand RLT Pipeline
Novartis has decided to acquire Mariana Oncology, a preclinical-stage biotechnology company based in Watertown, Massachusetts focused on developing novel radioligand therapies (RLTs) to treat cancers with high unmet patient needs.
Radioligand Therapies | 04/05/2024 | By Aishwarya | 229
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy